Pink Sheet is part of the Informa Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Utah Court Overturns Ephedra Ban For Low-Dose Products

This article was originally published in The Tan Sheet

Executive Summary

A Utah federal court has barred FDA from enforcing its ban on ephedra products containing 10 mg or less of ephedrine alkaloids per daily dose

Related Content

Ephedra appeal
Nutraceutical Files For Appellate Court Rehearing Of Ephedra Ban Suit
FDA “Misrepresented” Ephedra Dosing With Use Of Old Label In Court – Emord
Firm Flouting Ephedra Ban Faces Product Seizure By U.S. Marshals
Science Supporting Ephedra Ban Fails FDA’s Own Standard – Nutraceutical
FDA ephedra appeal
FDA Must Clarify Ephedra Case Impact – Supplement Trade Groups
FDA Must Recognize Ephedra Ruling’s Nationwide Implications – Emord
NBTY Eschews Ephedra, Eyes Acquisitions In Back Half Of Fiscal ’05
Utah Ephedra Ruling Clarified For Trade Group Members





Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts